The University of Kentucky division of gastroenterology and hepatology has been officially designated as an Alpha-1 Foundation Clinical Resource Center (CRC), a prestigious recognition that places UK HealthCare among a select national network of leading research and clinical institutions dedicated to the care of patients with alpha-1 antitrypsin deficiency (AATD).
As part of the designation, Venkata Rajesh Konjeti, M.B.B.S, has been named the site's designated hepatology provider, with Kaitlyn Johnson serving as the designated nurse. Together, they will help lead UK HealthCare’s efforts to advance care, education and research opportunities for individuals affected by this complex genetic condition.
The CRC designation highlights the expertise of the division of gastroenterology and hepatology in the management of complex liver disease and strengthens its role as a regional referral center for patients with AATD throughout Kentucky and surrounding states. The recognition reflects UK HealthCare's commitment to delivering specialized, multidisciplinary care while expanding access to innovative treatment and research opportunities.
AATD is an inherited disorder that can cause progressive damage to both the liver and lungs, often requiring coordinated care from multiple specialties. As a designated Clinical Resource Center, the University of Kentucky is uniquely positioned to provide comprehensive, patient-centered care by integrating hepatology, pulmonology, genetic counseling and transplant services when appropriate.
The designation also brings significant benefits for patients and families. In addition to receiving advanced, evidence-based clinical care, patients will gain access to the Alpha-1 Foundation's extensive educational resources, patient support programs and national Research Registry. These resources can help connect patients with clinical trials, emerging therapies and a broader network of experts focused on improving outcomes for individuals living with AATD.
This achievement represents an important milestone and reinforces the division of gastroenterology and hepatology’s growing clinical and academic footprint in the region. Through collaboration, innovation and specialized expertise, the University of Kentucky continues to expand opportunities for patients with rare and complex liver diseases while advancing the standard of care for the communities it serves.